Myelodysplastic Syndrome with Ring Sideroblasts
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome with Ring Sideroblasts.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-04-03FDA Approved: REBLOZYL — Original Application (Celgene Corporation)
FDA approved Reblozyl (luspatercept) in the original application for adults with transfusion-dependent anemia due to myelodysplastic syndrom…
-
FDA approval · 2019-11-08FDA Approved: REBLOZYL — Original Application (Celgene Corporation)
The FDA approved the original application for Reblozyl (luspatercept) from Celgene. This adds a new biologic for adults with transfusion-dep…